AIIMS Delhi begins registration for conducting human trials of indigenously developed coronavirus vaccine COVAXIN

AIIMS, Delhi has started the registration process for conducting the human trials of COVAXIN, today.

Principal Investigator for conducting these trials at one of the top medical institutes in the country, AIIMS Delhi , Dr. Sanjay Rai has said that the response for registration has been overwhelming.

Speaking exclusively to a News channel, Dr. Rai said that the first dose of the vaccine is likely to be administered to the volunteers on this Thursday.